GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (NAS:PHAR) » Definitions » Cyclically Adjusted FCF per Share

Pharming Group (Pharming Group) Cyclically Adjusted FCF per Share : $0.33 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Pharming Group Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pharming Group's adjusted free cash flow per share for the three months ended in Dec. 2023 was $0.128. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.33 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Pharming Group's average Cyclically Adjusted FCF Growth Rate was 50.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pharming Group was 47.70% per year. The lowest was 47.70% per year. And the median was 47.70% per year.

As of today (2024-04-28), Pharming Group's current stock price is $9.8003. Pharming Group's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.33. Pharming Group's Cyclically Adjusted Price-to-FCF of today is 29.70.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharming Group was 66.15. The lowest was 29.37. And the median was 53.85.


Pharming Group Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Pharming Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Cyclically Adjusted FCF per Share Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.60 - 0.20 0.33

Pharming Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.22 0.22 0.19 0.33

Competitive Comparison of Pharming Group's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Pharming Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharming Group's Cyclically Adjusted Price-to-FCF falls into.



Pharming Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharming Group's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.128/126.4000*126.4000
=0.128

Current CPI (Dec. 2023) = 126.4000.

Pharming Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.166 99.390 -0.211
201406 -0.214 99.240 -0.273
201409 -0.049 99.960 -0.062
201412 0.347 99.050 0.443
201503 -0.110 99.750 -0.139
201506 -0.146 100.230 -0.184
201509 -0.102 100.500 -0.128
201512 -0.091 99.730 -0.115
201603 -0.085 100.310 -0.107
201606 -0.162 100.260 -0.204
201609 -0.099 100.570 -0.124
201612 0.053 100.710 0.067
201703 -0.129 101.440 -0.161
201706 -0.020 101.370 -0.025
201709 0.256 102.030 0.317
201712 0.561 101.970 0.695
201803 -0.033 102.470 -0.041
201806 0.172 103.100 0.211
201809 0.249 103.950 0.303
201812 0.258 103.970 0.314
201903 0.158 105.370 0.190
201906 0.232 105.840 0.277
201909 0.054 106.700 0.064
201912 0.278 106.800 0.329
202003 0.193 106.850 0.228
202006 0.300 107.510 0.353
202009 0.238 107.880 0.279
202012 0.245 107.850 0.287
202103 0.063 108.870 0.073
202106 0.053 109.670 0.061
202109 0.033 110.790 0.038
202112 0.147 114.010 0.163
202203 0.003 119.460 0.003
202206 0.038 119.050 0.040
202209 0.182 126.890 0.181
202212 0.070 124.940 0.071
202303 -0.358 124.720 -0.363
202306 -0.155 125.830 -0.156
202309 0.048 127.160 0.048
202312 0.128 126.400 0.128

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Pharming Group  (NAS:PHAR) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pharming Group's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=9.8003/0.33
=29.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pharming Group was 66.15. The lowest was 29.37. And the median was 53.85.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pharming Group Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Pharming Group's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group (Pharming Group) Business Description

Industry
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.